Cantargia
Develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.
Market cap
$65.7m
Enterprise value
$60m
Share price
€0.21 7V3.F
Company register number
556791-6019
Authorizing premium user...